ReposiTrak (TRAK) Cash & Equivalents (2010 - 2025)

ReposiTrak's Cash & Equivalents history runs 16 years deep, the most recent figure standing at $28.7 million for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 2.37% year-over-year to $28.7 million; the TTM figure through Dec 2025 stood at $28.7 million (up 2.37% YoY), while the FY2025 annual figure was $28.6 million, up 13.58% from the prior year.
• Cash & Equivalents was $28.7 million for Q4 2025 at ReposiTrak, roughly flat from $28.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $28.8 million in Q3 2025 to a low of $20.4 million in Q3 2021.
• Historically, Cash & Equivalents has averaged $24.3 million across 5 years, with a median of $23.8 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents increased 29.59% in 2021, then decreased 10.84% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $21.7 million in 2021, then slipped by 1.42% to $21.4 million in 2022, then increased by 8.66% to $23.3 million in 2023, then climbed by 20.59% to $28.0 million in 2024, then advanced by 2.37% to $28.7 million in 2025.
• The last three Cash & Equivalents figures came in at $28.7 million (Q4 2025), $28.8 million (Q3 2025), and $28.6 million (Q2 2025), per Business Quant data.